Unusual 11 Mid-Day Movers 07/13: ADCT, STXS, THLD, OREX, YRCW, VVUS Higher; AMED, CVLT, BPZ, IFLG, BMTI Lower
ADC Telecom (Nasdaq: ADCT) 41.5% HIGHER; Tyco Electronics (NYSE: TEL) to acquire ADC for $12.75/share. Click here to see the full report.
Sereotaxis, Inc. (Nasdaq: STXS) 24.8% HIGHER; announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
Threshold Pharmaceuticals, Inc. (Nasdaq: THLD) 24.8% HIGHER; today announced two preclinical presentations on its clinical stage hypoxia-activated prodrug, TH-302, at the American Association for Cancer Research Translational Cancer Medicine Meeting, being held July 11 to 14, 2010, in San Francisco, CA. The preclinical presentations describe new findings regarding the efficacy of TH-302 when combined with multi-kinase inhibitors that inhibit VEGF signaling, as well as the efficacy of TH-302 in combination with gemcitabine in models of pancreatic cancer. View the release for more details.
Amedisys, Inc. (NASDAQ: AMED) 24.7% LOWER; sees Q2 EPS of $1.12, including items. Click here to see the full report. The stock was also downgraded at RBC.
Orexigen (Nasdaq: OREX) 22.1% HIGHER; seeing upside today following news that an FDA advisory panel has said that Vivus' diet pill led to "statistically significant" weight loss.
CommVault (Nasdaq: CVLT) 19.9% LOWER; expects to report revenue for the first quarter of approximately $66.3 million. (Consensus is $71.55 million) Software revenue is expected to be approximately $28.3 million and services revenue is expected to be approximately $38.0 million. Non-GAAP earnings per diluted share are expected to be approximately $0.11 using a Non-GAAP effective tax rate of 34%. (Consensus is $0.17) The stock was also downgraded at Stifel Nicolaus.
YRC Worldwide Inc. (Nasdaq: YRCW) 16.4% HIGHER; continuing higher today after issuing their expected second quarter results yesteray. They see their adjusted EBITDA at $24 - $36 million, shooting past the $5 million covenant level required in their credit agreement. Click here for more from the release.
VIVUS (Nasdaq: VVUS) 14.7% HIGHER; see Orexigen.
BPZ Resources, Inc. (NYSE: BPZ) 11.1% LOWER; announces completion of its CX11-22D well and spudding of the CX11-23D well in Corvina, and provides an update on production, Albacora oil sales, and status of the Extended Well Testing permitting process. Click here to see the full report. The stock was also downgraded at Morgan Keegan.
InfoLogix, Inc. (Nasdaq: IFLG) 9.9% LOWER; pulling back a little today after over a 30% move to the upside yesterday. We noted that there may have been an ascending triangle pattern forming over the last week to week-and-a-half, which the stock broke out of yesterday on gobs of volume. IFLG may be one to watch. Shares closed up 28.5% higher yesterday.
BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) 8.5% LOWER; announced today a public offering of 5,000,000 shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers..
Sereotaxis, Inc. (Nasdaq: STXS) 24.8% HIGHER; announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
Threshold Pharmaceuticals, Inc. (Nasdaq: THLD) 24.8% HIGHER; today announced two preclinical presentations on its clinical stage hypoxia-activated prodrug, TH-302, at the American Association for Cancer Research Translational Cancer Medicine Meeting, being held July 11 to 14, 2010, in San Francisco, CA. The preclinical presentations describe new findings regarding the efficacy of TH-302 when combined with multi-kinase inhibitors that inhibit VEGF signaling, as well as the efficacy of TH-302 in combination with gemcitabine in models of pancreatic cancer. View the release for more details.
Amedisys, Inc. (NASDAQ: AMED) 24.7% LOWER; sees Q2 EPS of $1.12, including items. Click here to see the full report. The stock was also downgraded at RBC.
Orexigen (Nasdaq: OREX) 22.1% HIGHER; seeing upside today following news that an FDA advisory panel has said that Vivus' diet pill led to "statistically significant" weight loss.
CommVault (Nasdaq: CVLT) 19.9% LOWER; expects to report revenue for the first quarter of approximately $66.3 million. (Consensus is $71.55 million) Software revenue is expected to be approximately $28.3 million and services revenue is expected to be approximately $38.0 million. Non-GAAP earnings per diluted share are expected to be approximately $0.11 using a Non-GAAP effective tax rate of 34%. (Consensus is $0.17) The stock was also downgraded at Stifel Nicolaus.
YRC Worldwide Inc. (Nasdaq: YRCW) 16.4% HIGHER; continuing higher today after issuing their expected second quarter results yesteray. They see their adjusted EBITDA at $24 - $36 million, shooting past the $5 million covenant level required in their credit agreement. Click here for more from the release.
VIVUS (Nasdaq: VVUS) 14.7% HIGHER; see Orexigen.
BPZ Resources, Inc. (NYSE: BPZ) 11.1% LOWER; announces completion of its CX11-22D well and spudding of the CX11-23D well in Corvina, and provides an update on production, Albacora oil sales, and status of the Extended Well Testing permitting process. Click here to see the full report. The stock was also downgraded at Morgan Keegan.
InfoLogix, Inc. (Nasdaq: IFLG) 9.9% LOWER; pulling back a little today after over a 30% move to the upside yesterday. We noted that there may have been an ascending triangle pattern forming over the last week to week-and-a-half, which the stock broke out of yesterday on gobs of volume. IFLG may be one to watch. Shares closed up 28.5% higher yesterday.
BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) 8.5% LOWER; announced today a public offering of 5,000,000 shares of its common stock. BioMimetic has granted the underwriters an option to purchase up to an additional 15% of shares of common stock to cover over-allotments. BioMimetic expects to use the net proceeds of the offering for development and commercialization of its product pipeline and general corporate purposes.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers..
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Stifel Nicolaus, Nelson Peltz, Trian Fund, Morgan Keegan & Company, Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
